Komori
Changes in Officers4886ASKA Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Subsidiary: Notice Regarding Personnel Changes at あすか製薬株式会社

4 employees of あすか製薬 will move to department-head and section-manager positions at the Iwaki Plant and in the International Business Division. At the Iwaki Plant, the head of Quality Control will change from head of Quality Control to head of Manufacturing, and the section manager in Quality Assurance will change from section manager in Quality Assurance to head of Quality Control. The head of International Business Department 1 and others will also change.

Worth reading
12Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
4
people
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 20 February 2026

Incoming appointee

4 items
Scheduled Appointment Date1 April 2026
根内 千彰
Previous position生産本部 いわき工場 品質管理部長
New position生産本部 いわき工場 製造部長
鈴木 智亮
Previous position生産本部 いわき工場 品質保証部 品質システム課長
New position生産本部 いわき工場 品質管理部長
大塩 啓介
Previous position国際事業本部 国際事業第1部長
New positionGeneral Manager of Supply Chain Management Department, Production Division
大熊 祐一朗
Previous position国際事業本部 国際事業第1部長付
New position国際事業本部 国際事業第1部長
Who is moving to which position
ItemDetails
Resolution date20 February 2026
Scheduled Appointment Date1 April 2026
Name of appointee根内 千彰, 鈴木 智亮, 大塩 啓介, 大熊 祐一朗
Appointee's new position生産本部 いわき工場 製造部長, 生産本部 いわき工場 品質管理部長, General Manager of Supply Chain Management Department, Production Division, 国際事業本部 国際事業第1部長
Appointee's previous position生産本部 いわき工場 品質管理部長, 生産本部 いわき工場 品質保証部 品質システム課長, 国際事業本部 国際事業第1部長, 国際事業本部 国際事業第1部長付
Items this document does not state (16)
Date of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

No reason for the personnel change was provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Subsidiary: Notice Regarding Personnel Changes at あすか製薬株式会社 | ASKA Pharmaceutical Holdings Co.,Ltd. (4886) timely disclosure | Komori